These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Better analysis for better decisions: has pharmacoeconomics come of age? Drummond M; Sculpher M Pharmacoeconomics; 2006; 24(2):107-8. PubMed ID: 16460132 [No Abstract] [Full Text] [Related]
4. Economics, pharmaceuticals, and pharmacoeconomics. Johannesson M; O'Brien BJ Med Decis Making; 1998; 18(2 Suppl):S1-3. PubMed ID: 9566460 [No Abstract] [Full Text] [Related]
5. Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria. Postma MJ; Boersma C; Gansevoort RT Nephrol Dial Transplant; 2008 Apr; 23(4):1103-6. PubMed ID: 17210586 [No Abstract] [Full Text] [Related]
6. Drug therapy: safety, effectiveness, and economics. Brandys J Przegl Lek; 2001; 58(4):226-8. PubMed ID: 11450340 [TBL] [Abstract][Full Text] [Related]
7. Applying patient outcomes and pharmacoeconomics in patient care. Proceedings of a conference. Boston, Massachusetts, September 1994. Am J Health Syst Pharm; 1995 Jul; 52(14 Suppl 3):S1-5. PubMed ID: 7552910 [No Abstract] [Full Text] [Related]
9. Expanding the role of pharmacists in pharmacoeconomics: why and how? Sanchez LA Pharmacoeconomics; 1994 May; 5(5):367-75. PubMed ID: 10147228 [No Abstract] [Full Text] [Related]
10. Pharmacoeconomics and immunotherapy. Berto P Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():12-6. PubMed ID: 18924461 [TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomics: an emerging discipline. Letizia C Qual Assur; 1995 Mar; 4(1):68-74. PubMed ID: 8520866 [TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomics of immunoglobulins and indications for their use. Guillevin L Curr Opin Allergy Clin Immunol; 2013 Jul; 13 Suppl 2():S53-5. PubMed ID: 23873314 [No Abstract] [Full Text] [Related]
13. Is there a role for pharmacoeconomics in developing countries? Velasco RP; Teerawattananon Y Pharmacoeconomics; 2011 May; 29(5):433-5; author reply 436-7. PubMed ID: 21504242 [No Abstract] [Full Text] [Related]
14. [Health economics: a major challenge for the pharmacist]. Astier A Ann Pharm Fr; 2013 Sep; 71(5):275-6. PubMed ID: 24075696 [No Abstract] [Full Text] [Related]
15. [Use of pharmacoeconomics analyses to health protection]. Drozd M Wiad Lek; 2002; 55 Suppl 1():76-9. PubMed ID: 15002222 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacoeconomics--survey and status]. Pedersen KM Ugeskr Laeger; 2003 Apr; 165(16):1670-4. PubMed ID: 12756827 [TBL] [Abstract][Full Text] [Related]
17. [Bioethics and pharmacoeconomics: a difficult balance]. Felicetti V; Cristina G; Cifaldi L Clin Ter; 2008; 159(1):29-32. PubMed ID: 18399259 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacoeconomics in contemporary medicine]. Czech M Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007 [TBL] [Abstract][Full Text] [Related]
19. Speaking from experience. Australia. Med Care; 1996 Dec; 34(12 Suppl):DS233-5. PubMed ID: 8999206 [No Abstract] [Full Text] [Related]
20. Economic assessment within the clinical development program. Schulman KA; Llana T; Yabroff KR Med Care; 1996 Dec; 34(12 Suppl):DS89-95. PubMed ID: 8969317 [No Abstract] [Full Text] [Related] [Next] [New Search]